Article

A Genetics-guided Integrative Framework for Drug Repurposing: Identifying Anti-hypertensive Drug Telmisartan for Type 2 Diabetes

2025-03-23

Abstract excerpt

<h4>ABSTRACT</h4> Drug development is a long and costly process, and repurposing existing drugs for use toward a different disease or condition may serve as a cost-effective alternative. As drug targets with genetic support have a doubled success rate, genetics-informed drug repurposing holds promise in translating genetic findings into therapeutics. In this study, we developed a Genetics Informed Network-based Dr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: acf10e45-2aff-5cc5-95df-fc774ae6c12e
DOI: 10.1101/2025.03.22.25324223

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Genetics-guided Integrative Framework for Drug Repurposing: Identifying Anti-hypertensive Drug Telmisartan for Type 2 DiabetesDOI 10.1101/2025.03.22.25324223Read

A genetically supported drug repurposing pipeline for diabetes treatment using electronic health recordsSemantic proximity Read

Leveraging Genetic Correlations to Prioritize Drug Groups for Repurposing in Type 2 DiabetesSemantic proximity Read

Prioritization of therapeutic targets for dyslipidemia using integrative multi-omics and multi-trait analysis.Semantic proximity Read

Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.Semantic proximity Read

Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related TraitsSemantic proximity Read

Using genome-wide association results to identify drug repurposing candidatesSemantic proximity Read

Integrating population-level and cell-based signatures for drug repositioningSemantic proximity Read

Pharmaceutical Repurposing Strategies for Metabolic Disorders: Insights from Mendelian Randomization StudiesSemantic proximity Read

Forecasting off-target drug toxicity using proteomic and genetic data: insights from TorcetrapibSemantic proximity Read

A genomic-led strategy to anticipate drug safety effects.Semantic proximity Read

A genomic-led strategy to anticipate drug safety effectsSemantic proximity Read

Integrated Bioinformatics and Pharmacogenomic Profiling of a Gene Panel in Diabetes Mellitus Treatment ResponseSemantic proximity Read